176 related articles for article (PubMed ID: 22762733)
21. Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis.
Wu YC; Zhang XM; Zhu YD; Wu W
Hematology; 2019 Dec; 24(1):60-69. PubMed ID: 30129389
[TBL] [Abstract][Full Text] [Related]
22. Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.
Ustun C; Trottier BJ; Sachs Z; DeFor TE; Shune L; Courville EL; Holtan SG; Dolan M; Weisdorf DJ; Warlick ED
Biol Blood Marrow Transplant; 2015 May; 21(5):866-72. PubMed ID: 25620751
[TBL] [Abstract][Full Text] [Related]
23. Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Lübbert M; Suciu S; Hagemeijer A; Rüter B; Platzbecker U; Giagounidis A; Selleslag D; Labar B; Germing U; Salih HR; Muus P; Pflüger KH; Schaefer HE; Bogatyreva L; Aul C; de Witte T; Ganser A; Becker H; Huls G; van der Helm L; Vellenga E; Baron F; Marie JP; Wijermans PW;
Ann Hematol; 2016 Jan; 95(2):191-9. PubMed ID: 26596971
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B
J Clin Oncol; 2012 Jun; 30(17):2140-6. PubMed ID: 22564995
[TBL] [Abstract][Full Text] [Related]
26. Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes.
McQuilten ZK; Sundararajan V; Andrianopoulos N; Curtis DJ; Wood EM; Campbell LJ; Wall M
Cancer; 2015 Sep; 121(17):2892-9. PubMed ID: 26043022
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
[TBL] [Abstract][Full Text] [Related]
28. [The prognosis and cytogenetic characteristics of acute erythroid leukemia: a report of 55 cases].
Liu J; Lu DP; Zhang Y
Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):738-40. PubMed ID: 17166448
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.
Lee JH; Lee JH; Lim SN; Kim DY; Kim SH; Lee YS; Kang YA; Kang SI; Jeon MJ; Seol M; Seo EJ; Chi HS; Park CJ; Jang S; Yun SC; Lee KH
Bone Marrow Transplant; 2010 Mar; 45(3):450-7. PubMed ID: 19668236
[TBL] [Abstract][Full Text] [Related]
30. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
[TBL] [Abstract][Full Text] [Related]
31. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.
Oran B; Kongtim P; Popat U; de Lima M; Jabbour E; Lu X; Chen J; Rondon G; Kebriaei P; Ahmed S; Andersson B; Alousi A; Ciurea S; Shpall E; Champlin RE
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1618-25. PubMed ID: 24953017
[TBL] [Abstract][Full Text] [Related]
33. Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation.
Choi Y; Lee JH; Seo EJ; Lee JH; Kim DY; Park CJ; Jang S; Cho YU; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
Ann Hematol; 2015 May; 94(5):795-801. PubMed ID: 25563594
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Papageorgiou SG; Vasilatou D; Kontos CK; Kotsianidis I; Symeonidis A; Galanopoulos AG; Hatzimichael E; Megalakaki A; Poulakidas E; Diamantopoulos P; Vassilakopoulos TP; Zikos P; Papadaki H; Mparmparousi D; Bouronikou E; Panayiotidis P; Viniou NA; Pappa V
Am J Hematol; 2018 Jul; 93(7):895-901. PubMed ID: 29659040
[TBL] [Abstract][Full Text] [Related]
35. Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndrome.
Xing R; Li C; Gale RP; Zhang Y; Xu Z; Qin T; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Am J Hematol; 2014 Oct; 89(10):E163-8. PubMed ID: 25044281
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease.
Andolina JR; Kletzel M; Tse WT; Jacobsohn DA; Duerst RE; Schneiderman J; Helenowski I; Rademaker A; Chaudhury S
Pediatr Transplant; 2011 May; 15(3):334-43. PubMed ID: 21492354
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Jo T; Arai Y; Oshima S; Kondo T; Harada K; Uchida N; Doki N; Fukuda T; Tanaka M; Ozawa Y; Kuriyama T; Ikegame K; Katayama Y; Ota S; Ara T; Kawakita T; Onizuka M; Ichinohe T; Atsuta Y; Yanada M;
Br J Haematol; 2023 Jul; 202(2):356-368. PubMed ID: 37211753
[TBL] [Abstract][Full Text] [Related]
38. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.
Gauthier J; Damaj G; Langlois C; Robin M; Michallet M; Chevallier P; Beguin Y; N'guyen S; Bories P; Blaise D; Cornillon J; Clavert A; Mohty M; Huynh A; Thiébaut-Bertrand A; Vigouroux S; Duhamel A; Yakoub-Agha I
Transplantation; 2015 Aug; 99(8):1672-80. PubMed ID: 25769079
[TBL] [Abstract][Full Text] [Related]
39. [Clinical Significance of Monosomal Karyotype in MDS].
Guo SS; Gao PP; Mu QT; Ouyang GF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):860-866. PubMed ID: 31204945
[TBL] [Abstract][Full Text] [Related]
40. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
Kayser S; Zucknick M; Döhner K; Krauter J; Köhne CH; Horst HA; Held G; von Lilienfeld-Toal M; Wilhelm S; Rummel M; Germing U; Götze K; Nachbaur D; Schlegelberger B; Göhring G; Späth D; Morlok C; Teleanu V; Ganser A; Döhner H; Schlenk RF;
Blood; 2012 Jan; 119(2):551-8. PubMed ID: 22096250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
